161 related articles for article (PubMed ID: 10850389)
1. Effect of a genetic polymorphism of CYP1A2 inducibility on the steady state plasma concentrations of haloperidol and reduced haloperidol in Japanese patients with schizophrenia.
Mihara K; Suzuki A; Kondo T; Yasui N; Furukori H; Nagashima U; Ono S; Kaneko S; Otani K; Inoue Y
Ther Drug Monit; 2000 Jun; 22(3):245-9. PubMed ID: 10850389
[TBL] [Abstract][Full Text] [Related]
2. Lack of impact of CYP1A2 genetic polymorphism (C/A polymorphism at position 734 in intron 1 and G/A polymorphism at position -2964 in the 5'-flanking region of CYP1A2) on the plasma concentration of haloperidol in smoking male Japanese with schizophrenia.
Shimoda K; Someya T; Morita S; Hirokane G; Yokono A; Takahashi S; Okawa M
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):261-5. PubMed ID: 11817502
[TBL] [Abstract][Full Text] [Related]
3. Effects of genetic polymorphism of CYP1A2 inducibility on the steady-state plasma concentrations of trazodone and its active metabolite m-chlorophenylpiperazine in depressed Japanese patients.
Mihara K; Kondo T; Suzuki A; Yasui-Furukori N; Ono S; Otani K; Kaneko S
Pharmacol Toxicol; 2001 May; 88(5):267-70. PubMed ID: 11393588
[TBL] [Abstract][Full Text] [Related]
4. Effects of various factors including the CYP2D6 genotype and coadministration of flunitrazepam on the steady-state plasma concentrations of bromperidol and its reduced metabolite.
Suzuki A; Otani K; Mihara K; Yasui N; Kondo T; Tokinaga N; Furukori H; Kaneko S; Inoue Y; Hayashi K
Psychopharmacology (Berl); 1998 Feb; 135(4):333-7. PubMed ID: 9539256
[TBL] [Abstract][Full Text] [Related]
5. Effects of the CYP2D6*10 allele on the steady-state plasma concentrations of haloperidol and reduced haloperidol in Japanese patients with schizophrenia.
Mihara K; Suzuki A; Kondo T; Yasui N; Furukori H; Nagashima U; Otani K; Kaneko S; Inoue Y
Clin Pharmacol Ther; 1999 Mar; 65(3):291-4. PubMed ID: 10096261
[TBL] [Abstract][Full Text] [Related]
6. Plasma concentrations of haloperidol are related to CYP2D6 genotype at low, but not high doses of haloperidol in Korean schizophrenic patients.
Roh HK; Chung JY; Oh DY; Park CS; Svensson JO; Dahl ML; Bertilsson L
Br J Clin Pharmacol; 2001 Sep; 52(3):265-71. PubMed ID: 11560558
[TBL] [Abstract][Full Text] [Related]
7. Effects of smoking, CYP2D6 genotype, and concomitant drug intake on the steady state plasma concentrations of haloperidol and reduced haloperidol in schizophrenic inpatients.
Pan L; Vander Stichele R; Rosseel MT; Berlo JA; De Schepper N; Belpaire FM
Ther Drug Monit; 1999 Oct; 21(5):489-97. PubMed ID: 10519444
[TBL] [Abstract][Full Text] [Related]
8. Lack of correlation between the steady-state plasma concentrations of aripiprazole and haloperidol in Japanese patients with schizophrenia.
Nakamura A; Mihara K; Nemoto K; Nagai G; Kagawa S; Suzuki T; Kondo T
Ther Drug Monit; 2014 Dec; 36(6):815-8. PubMed ID: 24739668
[TBL] [Abstract][Full Text] [Related]
9. Effects of the CYP2D6 genotype on the steady-state plasma concentrations of haloperidol and reduced haloperidol in Japanese schizophrenic patients.
Suzuki A; Otani K; Mihara K; Yasui N; Kaneko S; Inoue Y; Hayashi K
Pharmacogenetics; 1997 Oct; 7(5):415-8. PubMed ID: 9352580
[No Abstract] [Full Text] [Related]
10. Haloperidol plasma concentration in Japanese psychiatric subjects with gene duplication of CYP2D6.
Ohnuma T; Shibata N; Matsubara Y; Arai H
Br J Clin Pharmacol; 2003 Sep; 56(3):315-20. PubMed ID: 12919180
[TBL] [Abstract][Full Text] [Related]
11. Lack of correlation between the steady-state plasma concentrations of haloperidol and risperidone.
Yasui-Furukori N; Kondo T; Mihara K; Suzuki A; Inoue Y; De Vries R; Kaneko S
J Clin Pharmacol; 2002 Oct; 42(10):1083-8. PubMed ID: 12362921
[TBL] [Abstract][Full Text] [Related]
12. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
Fu Y; Fan CH; Deng HH; Hu SH; Lv DP; Li LH; Wang JJ; Lu XQ
Acta Pharmacol Sin; 2006 Mar; 27(3):328-32. PubMed ID: 16490169
[TBL] [Abstract][Full Text] [Related]
13. Depot haloperidol treatment in outpatients with schizophrenia on monotherapy: impact of CYP2D6 polymorphism on pharmacokinetics and treatment outcome.
Panagiotidis G; Arthur HW; Lindh JD; Dahl ML; Sjöqvist F
Ther Drug Monit; 2007 Aug; 29(4):417-22. PubMed ID: 17667795
[TBL] [Abstract][Full Text] [Related]
14. [Effect of smoking on pharmacokinetics of antipsychotics].
Shimoda K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Apr; 24(2):67-70. PubMed ID: 15164612
[TBL] [Abstract][Full Text] [Related]
15. Role of the smoking-induced cytochrome P450 (CYP)1A2 and polymorphic CYP2D6 in steady-state concentration of olanzapine.
Carrillo JA; Herráiz AG; Ramos SI; Gervasini G; Vizcaíno S; Benítez J
J Clin Psychopharmacol; 2003 Apr; 23(2):119-27. PubMed ID: 12640212
[TBL] [Abstract][Full Text] [Related]
16. Genetic association analysis of functional polymorphisms in the cytochrome P450 1A2 (CYP1A2) gene with tardive dyskinesia in Japanese patients with schizophrenia.
Matsumoto C; Ohmori O; Shinkai T; Hori H; Nakamura J
Psychiatr Genet; 2004 Dec; 14(4):209-13. PubMed ID: 15564895
[TBL] [Abstract][Full Text] [Related]
17. The Influence of the CYP3A4*22 Polymorphism and CYP2D6 Polymorphisms on Serum Concentrations of Aripiprazole, Haloperidol, Pimozide, and Risperidone in Psychiatric Patients.
van der Weide K; van der Weide J
J Clin Psychopharmacol; 2015 Jun; 35(3):228-36. PubMed ID: 25868121
[TBL] [Abstract][Full Text] [Related]
18. The effect of cytochrome P450 2D6 genotypes on haloperidol metabolism: a preliminary study in a psychiatric population.
Someya T; Suzuki Y; Shimoda K; Hirokane G; Morita S; Yokono A; Inoue Y; Takahashi S
Psychiatry Clin Neurosci; 1999 Oct; 53(5):593-7. PubMed ID: 10595685
[TBL] [Abstract][Full Text] [Related]
19. Cigarette smoking and heavy coffee consumption affecting response to olanzapine: The role of genetic polymorphism.
Djordjevic N; Radmanovic B; Cukic J; Baskic D; Djukic-Dejanovic S; Milovanovic D; Aklillu E
World J Biol Psychiatry; 2020 Jan; 21(1):29-52. PubMed ID: 30513034
[No Abstract] [Full Text] [Related]
20. Genetic polymorphism in the 5'-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans.
Nakajima M; Yokoi T; Mizutani M; Kinoshita M; Funayama M; Kamataki T
J Biochem; 1999 Apr; 125(4):803-8. PubMed ID: 10101295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
